Please assess the completion status of the following clinical trial:

Trial Title: Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* History of ulcerative colitis, inflammatory bowel disease unclassified, indeterminate colitis, or Crohn's disease;~* Major colorectal surgery, defined as surgery requiring an abdominal incision. Both open and laparoscopic procedures are eligible. Urgent and elective procedures are eligible;~* Corticosteroid therapy within 12 months of surgery;~* Able and willing to comply with all protocol procedures for the planned duration of the study~* Able and willing to understand, sign and date an informed consent document, and authorize access to protected health information.~Exclusion Criteria:~* Patients with hypotension (systolic \< 90 mm Hg or diastolic \< 50 mm Hg) in the preoperative area~* Patients having emergency surgery~* Children \< 18 or adults \> 75 years of age~* Pregnant patients~* Patients who have suffered prior hemodynamic complications of steroid withdrawal~* Other major physical or major psychiatric illness, including alcohol or substance addiction, within the last 6 months that in the opinion of the investigator would affect the patient's ability to complete the trial.~* Any condition or situation that, in the opinion of the investigator, would prevent proper evaluation of the safety or efficacy of the different steroid doses according to the study protocol~* Patients on steroids without inflammatory bowel disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Hydrocortisone High Dose (Type: ACTIVE_COMPARATOR): Intervention: Patients receive Hydrocortisone 100 mg at surgical incision followed by 100mg IV every 8 hours for the first 24 hours, followed by 75 mg IV every 8 hours for 24 hours, followed by 50 mg IV every 8 hours for 24 hours, followed by 50 mg IV every 12 hours, followed by Prednisone 20 mg orally when oral diet is resumed
- Hydrocortisone Low Dose (Type: EXPERIMENTAL): Intervention: 1/3 Intravenous equivalent dose (IVED) at surgical incision, followed by 1/3 IVED for 24 hours, Patients subsequently treated with 1/4 IVED every 8 hours starting Postoperative day (POD) 1, followed by 1/6 IVED every 8 hours on POD 2 and every 12 hours starting POD 3. On POD 4 or when the patient was tolerating a regular diet, oral prednisone equal to the most recent IV hydrocortisone dose resumed

Based on this trial design, predict the completion outcome and termination type (if applicable).